KEGG pathway enrichment analysis showed that the key targets of CS against cataracts were mainly enriched in the thyroid hormone signaling pathway, MAPK signaling pathway, and PI3K-Akt signaling pathway, indicating the involvement of these pathways in the treatment of cataracts. This evidence concerns the gene AKT1 and cataract.